REAL-WORLD DATA (RWD) MARKET ANALYSIS

Market News

Recent Developments

New product launches

• On October 2, 2023, Oncology real-world data and analytics company COTA, announced the launch of Vista, a large-scale automated electronic health record (EHR) dataset. Cota developed Vista using automation to increase the pace, and therefore scale, of EHR data abstraction in order both to advance real-world evidence (RWE) insights in oncology and to pave the way for the development of trusted generative AI in cancer care.
• On August 23, 2023, Real-world evidence (RWE) leader, Target RWE, announced the launch of its pioneering suite of advanced analytical solutions. Designed to identify unmet needs and answer critical strategic questions along a pharmaceutical product's life cycle, the novel solutions visualize and analyze data using innovative epidemiological methods and sound statistical principles.
• On July 19, 2023, Compile, a novel provider of life sciences data products, announced the launch of Multi-Payer Complete Claims ReadyData, a dataset that will allow life sciences and biotech companies to conduct more granular analyses, leading to more optimized drug commercialization and reimbursement strategies.

Acquisition and partnerships

• On June 1, 2023, BC Platforms (BCP), a global leader in healthcare data management and analytics, announced the acquisition of 4Pharma Ltd, a well-established contract research organization providing medical research services to pharmaceutical, biotechnology, and medical device companies.
• In August 2022, Target RWE, a real-world evidence leader, announced its acquisition of the curation team (legacy Real World Data team) from Ciox Health, a healthcare information management company, which will expand the company's global real world data (RWD) (RWD) solutions and capabilities.
• In December 2021, Thermo Fisher Scientific Inc., the world leader in serving science, announced that it had completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industries, for US$17.4 billion. Through this acquisition, Thermo Fisher Scientific Inc. is expanding their value proposition for their biotech and pharmaceutical customers with the addition of PPD's leading clinical research services, which advances their work in bringing life-changing therapies to market, benefiting patients around the world.
• In December 2021, Oracle Corporation, a computer software company, acquired Cerner Corp., a provider of electronic health records (EHRs), to transform healthcare delivery by providing medical professionals with better information—enabling them to make better treatment decisions resulting in better patient outcomes.